Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Guindo Chirfi | Chief Marketing Officer | Aug 05 '24 | Option Exercise | 115.20 | 36,901 | 4,250,995 | 57,782 | Aug 06 12:20 PM | Smart Dalton | SVP Fin. - Global Controller | May 03 '24 | Option Exercise | 128.26 | 2,046 | 262,420 | 4,708 | May 06 04:10 PM | Smart Dalton | SVP Fin. - Global Controller | May 04 '24 | Option Exercise | 127.51 | 612 | 78,036 | 4,730 | May 06 04:10 PM | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | May 04 '24 | Option Exercise | 127.51 | 27,126 | 3,458,836 | 163,720 | May 06 04:08 PM | Klobuchar Michael A | EVP - Chief Strategy Officer | May 04 '24 | Option Exercise | 127.51 | 887 | 113,101 | 24,058 | May 06 04:06 PM | Oosthuizen Johannes Jacobus | President, U.S. Market | May 04 '24 | Option Exercise | 127.51 | 912 | 116,289 | 24,271 | May 06 04:01 PM | Romanelli Joseph | President, Human Health Int?l | May 02 '24 | Option Exercise | 128.80 | 2,262 | 291,346 | 21,831 | May 02 04:29 PM | Smart Dalton | SVP Fin. - Global Controller | May 02 '24 | Option Exercise | 128.80 | 381 | 49,073 | 3,048 | May 02 04:23 PM | Merck & Co., Inc. | 10% Owner | Mar 11 '24 | Buy | 23.00 | 21,397,205 | 492,135,715 | 1,000 | Mar 11 03:27 PM | Litchfield Caroline | EVP & CFO | Feb 14 '24 | Option Exercise | 58.08 | 38,291 | 2,223,941 | 89,199 | Feb 15 04:03 PM | Litchfield Caroline | EVP & CFO | Feb 14 '24 | Sale | 125.50 | 38,291 | 4,805,520 | 50,908 | Feb 15 04:03 PM | Davis Robert M | Chairman, CEO & President | Feb 13 '24 | Option Exercise | 74.18 | 150,000 | 11,127,160 | 498,327 | Feb 15 04:01 PM | Davis Robert M | Chairman, CEO & President | Feb 14 '24 | Option Exercise | 73.73 | 85,021 | 6,268,598 | 433,348 | Feb 15 04:01 PM | Davis Robert M | Chairman, CEO & President | Feb 13 '24 | Sale | 125.85 | 150,000 | 18,877,424 | 348,327 | Feb 15 04:01 PM | Davis Robert M | Chairman, CEO & President | Feb 14 '24 | Sale | 125.40 | 85,021 | 10,661,574 | 348,327 | Feb 15 04:01 PM | Romanelli Joseph | President, Human Health Int?l | Feb 13 '24 | Sale | 124.89 | 1,000 | 124,888 | 19,569 | Feb 14 04:03 PM | Li Dean Y | Executive VP & President, MRL | Feb 09 '24 | Option Exercise | 62.07 | 14,702 | 912,553 | 60,944 | Feb 12 04:03 PM | Li Dean Y | Executive VP & President, MRL | Feb 09 '24 | Sale | 125.50 | 14,702 | 1,845,083 | 46,242 | Feb 12 04:03 PM | Williams David Michael | EVP,Chief Info&Digital Officer | Feb 07 '24 | Sale | 127.57 | 1,451 | 185,108 | 19,812 | Feb 08 04:04 PM | Oosthuizen Johannes Jacobus | President, U.S. Market | Feb 02 '24 | Option Exercise | 78.80 | 20,937 | 1,649,906 | 42,286 | Feb 05 04:01 PM | Oosthuizen Johannes Jacobus | President, U.S. Market | Feb 02 '24 | Sale | 127.17 | 18,959 | 2,411,111 | 23,327 | Feb 05 04:01 PM | MIZELL STEVEN | EVP, Chief HR Officer | Feb 02 '24 | Option Exercise | 73.65 | 32,994 | 2,430,159 | 74,313 | Feb 02 04:07 PM | MIZELL STEVEN | EVP, Chief HR Officer | Feb 02 '24 | Sale | 126.65 | 50,694 | 6,420,349 | 23,619 | Feb 02 04:07 PM | Zachary Jennifer | EVP, General Counsel | Feb 02 '24 | Option Exercise | 87.10 | 19,417 | 1,691,221 | 78,557 | Feb 02 04:05 PM | Zachary Jennifer | EVP, General Counsel | Feb 02 '24 | Sale | 126.97 | 49,499 | 6,284,779 | 29,058 | Feb 02 04:05 PM | Oosthuizen Johannes Jacobus | President, U.S. Market | Nov 09 '23 | Sale | 102.38 | 2,081 | 213,061 | 18,191 | Nov 13 07:36 AM | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | Nov 08 '23 | Sale | 105.03 | 43,823 | 4,602,668 | 111,764 | Nov 09 09:04 AM | Oosthuizen Johannes Jacobus | President, U.S. Market | Oct 30 '23 | Option Exercise | 102.82 | 915 | 94,080 | 20,723 | Oct 31 11:08 AM |
|